CONSOLIDATION THERAPY WITH ENTECAVIR CAN PREVENT POST-TREATMENT HBsAg REBOUND IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALPHA

Basit Öğe Kaydı
dc.contributor.authorBrouwer, W. P.
dc.contributor.authorSonneveld, M. J.
dc.contributor.authorXie, Q.
dc.contributor.authorZhang, N.
dc.contributor.authorZeuzem, S.
dc.contributor.authorTabak, F.
dc.contributor.authorZhang, Q.
dc.contributor.authorSimon, K.
dc.contributor.authorAkarca, U. S.
dc.contributor.authorStreinu-Cercel, A.
dc.contributor.authorHansen, B.
dc.contributor.authorJanssen, H. L.
dc.date.accessioned2019-10-27T22:27:17Z
dc.date.available2019-10-27T22:27:17Z
dc.date.issued2015
dc.departmentEge Üniversitesien_US
dc.description50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver -- APR 22-26, 2015 -- Vienna, AUSTRIAen_US
dc.description.sponsorshipEuropean Assoc Study Liveren_US
dc.identifier.doi10.1016/S0168-8278(15)30873-4
dc.identifier.endpageS573en_US
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.startpageS572en_US
dc.identifier.urihttps://doi.org/10.1016/S0168-8278(15)30873-4
dc.identifier.urihttps://hdl.handle.net/11454/50627
dc.identifier.volume62en_US
dc.identifier.wosWOS:000362830600386en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofJournal of Hepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCONSOLIDATION THERAPY WITH ENTECAVIR CAN PREVENT POST-TREATMENT HBsAg REBOUND IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALPHAen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu